Atrasentan (Atrasentan) purchasing channels and precautions
Atrasentan (atrasentan), as an endothelinA receptor antagonist, has a strong effect in reducing proteinuria, which makes it show a certain therapeutic effect in the treatment of patients with primary immunoglobulin A nephropathy. One of the advantages of atrasentan in the treatment of diabeticprimaryIgA nephropathy is its significant reduction in proteinuria. Many studies have shown that patients taking atrasentan are able to reduce proteinuria levels in a shorter period of time, an effect that helps slow the progression of the disease.
Since atrasentan has been on the market for a short time in China and has not been widely popularized yet, it cannot be purchased through conventional pharmacies or medical channels for the time being. Despite this, atrasentan has been approved and marketed in some overseas markets, especially for the treatment of patients with diseases such as IgA nephropathy. Internationally, the common specification of atrasentan is 0.75mg*30 tablets, and the price is about US$13,000, which is relatively expensive. Since the clinical application of atrasentan is mainly concentrated in the field of kidney disease treatment, its price is mainly affected by market demand and drug patents.
For domestic patients who urgently need atrasentan, they can purchase it through some cross-border e-commerce platforms or international drug suppliers. However, when purchasing overseas medicines, you should be particularly careful to ensure that the medicines are from legitimate sources to avoid buying counterfeit medicines or medicines whose quality cannot be guaranteed. During this process, it is recommended to seek guidance from professional medical institutions or physicians to ensure that the purchased drugs meet relevant medical needs.
At present, because atrasentan is an innovative drug, there are no generic drugs on the market at home or abroad, and it is not included in the medical insurance catalog. Therefore, the price is still a high burden for most patients. When considering purchasing this drug, patients need to weigh its price, efficacy, and whether there are alternatives to the drug.
Reference materials:https://www.vanrafia.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)